Filing Flows

Filing Flows › Amgen (AMGN) › Recalls, complaints & regulation

Amgen (AMGN): recalls, clinical trials and Federal Register

Amgen (AMGN) beyond its filings: 5 recalls in the last 12 months (8 in five years, 0 Class I); 4 Federal Register documents in a year; 103 active clinical trials.

Latest recalls

Amgen's latest quarter

Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.

Questions

Has Amgen had any recalls?

8 recalls on file over five years from the FDA, CPSC and NHTSA; 5 in the last 12 months.

How many clinical trials does Amgen have?

103 active studies on ClinicalTrials.gov, 50 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.